In drug development, natural compounds (e.g., curcumin, quercetin) and several small-molecule inhibitors have been shown to directly suppress LDHA activity, shifting tumor metabolism from glycolysis toward mitochondrial OXPHOS. Here, LDHA is linked to neoplasm.